More recently, one case of rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination was described in a patient with carnitine palmitoyltransferase II (CPT II) deficiency [6]. This evidence concerns the gene CPT2 and rhabdomyolysis.